Search Results - "Ebrahimi, Soltan A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS‐CoV‐2 by Ebrahimi, Soltan A.

    Published in Drug development research (01-11-2020)
    “…Successful treatment of viral infections has proven to be huge challenge for modern medicine with the most effective approach being prior vaccination. The…”
    Get full text
    Journal Article
  2. 2

    Identification of nontuberculous mycobacteria by high-performance liquid chromatography from patients in tehran by Mirzapour, Ali, Alam, Ali Nazari, Bostanabadi, Saeed Z, Shahraki, Abdolrazagh H, Ebrahimi, Soltan A, Yousefi, Masoud

    Published in International journal of mycobacteriology (01-12-2016)
    “…Abstract Background/Objectives The genus Mycobacterium contains over 140 species comprises pathogenic and nonpathogenic strains. Nontuberculous mycobacteria…”
    Get full text
    Journal Article
  3. 3

    Oral administration of phenylalanine molecularly imprinted polymer (MIP) benefits PKU mouse model by Torab, Mansour, Jafari‐Sabet, Majid, Najafizadeh, Parvaneh, Sadegipour, Alireza, Rahimi‐Moghaddam, Parvaneh, Ebrahimi, Soltan A.

    Published in Journal of inherited metabolic disease (01-07-2022)
    “…Phenylketonuria (PKU) is a rare genetic disorder caused by a defect in the metabolism of phenylalanine (Phe). Currently, the most commonly used treatment for…”
    Get full text
    Journal Article